Teva To Present Data Highlighting Company’s Pipeline In Neurological Disorders At 68th American Academy of Neurology Annual Meeting

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced new data for four of the Company’s innovative specialty products will be presented at the 68th American Academy of Neurology (AAN) Annual Meeting in Vancouver, B.C., April 15-21, 2016.

Teva-sponsored data will be highlighted in three platform presentations and multiple poster presentations.